ZA200001593B - Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz [B,E] oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization. - Google Patents
Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz [B,E] oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization.Info
- Publication number
- ZA200001593B ZA200001593B ZA200001593A ZA200001593A ZA200001593B ZA 200001593 B ZA200001593 B ZA 200001593B ZA 200001593 A ZA200001593 A ZA 200001593A ZA 200001593 A ZA200001593 A ZA 200001593A ZA 200001593 B ZA200001593 B ZA 200001593B
- Authority
- ZA
- South Africa
- Prior art keywords
- dimethylaminopropylidene
- dihydrodibenz
- oxepin
- medicament
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9276298P | 1998-07-14 | 1998-07-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200001593B true ZA200001593B (en) | 2000-10-25 |
Family
ID=22235027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200001593A ZA200001593B (en) | 1998-07-14 | 2000-03-29 | Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz [B,E] oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1037627B1 (zh) |
JP (1) | JP2002520355A (zh) |
KR (1) | KR100598723B1 (zh) |
CN (1) | CN1114401C (zh) |
AR (1) | AR019916A1 (zh) |
AT (1) | ATE203668T1 (zh) |
AU (1) | AU742237B2 (zh) |
BR (1) | BR9906772A (zh) |
CA (1) | CA2306393C (zh) |
DE (1) | DE69900207T2 (zh) |
DK (1) | DK1037627T3 (zh) |
ES (1) | ES2159209T3 (zh) |
GR (1) | GR3036422T3 (zh) |
HK (1) | HK1030362A1 (zh) |
PT (1) | PT1037627E (zh) |
TW (1) | TW561046B (zh) |
WO (1) | WO2000003705A1 (zh) |
ZA (1) | ZA200001593B (zh) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2374002A1 (en) * | 1999-06-18 | 2000-12-28 | Alcon Laboratories, Inc. | Topical ophthalmic mast cell stabilizers for treating allergic eye diseases |
US20020077358A1 (en) * | 2000-10-23 | 2002-06-20 | Alcon Universal Ltd. | Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery |
US7112588B2 (en) | 2001-05-21 | 2006-09-26 | Alcon, Inc. | Use of proteasome inhibitors to treat dry eye disorders |
DE60213230T2 (de) * | 2001-05-21 | 2006-11-23 | Alcon Inc. | Verwendung von NF-Kappa.B Inhibitoren zur Behandlung von Augentrockenheit |
US6872382B1 (en) | 2001-05-21 | 2005-03-29 | Alcon, Inc. | Use of selective PDE IV inhibitors to treat dry eye disorders |
AU2002308760B2 (en) | 2001-05-21 | 2006-05-11 | Alcon, Inc. | Use of proteasome inhibitors to treat dry eye disorders |
US6645994B1 (en) | 2001-06-01 | 2003-11-11 | Alcon, Inc. | Method of treating dry eye disorders |
US7977376B2 (en) | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
TWI231759B (en) | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
EP1583527A1 (en) | 2002-06-14 | 2005-10-12 | Alcon, Inc. | Use of hydroxyeicosatetraenoic acid compounds to treat ophthalmic inflammatory disorders |
CN101327325A (zh) * | 2002-07-30 | 2008-12-24 | 奥默罗斯公司 | 眼科冲洗液及方法 |
PL374700A1 (en) | 2002-09-20 | 2005-10-31 | Alcon, Inc. | Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
WO2004093878A1 (en) * | 2003-04-16 | 2004-11-04 | Alcon, Inc. | Use of fused pyridazine derivatives for treating dry eye disorders |
US20050232972A1 (en) | 2004-04-15 | 2005-10-20 | Steven Odrich | Drug delivery via punctal plug |
US7923471B2 (en) | 2004-05-14 | 2011-04-12 | Alcon, Inc. | Method of treating dry eye disorders and uveitis |
EP3470108A1 (en) | 2004-07-02 | 2019-04-17 | Mati Therapeutics Inc. | Treatment medium delivery device for delivery of treatment media to the eye |
US7223737B1 (en) | 2004-08-13 | 2007-05-29 | Alcon, Inc. | Method of treating dry eye disorders using glycosides |
ES2614080T3 (es) | 2005-05-17 | 2017-05-29 | Sarcode Bioscience Inc. | Composiciones y métodos para el tratamiento de trastornos oculares |
US7745461B1 (en) | 2006-02-27 | 2010-06-29 | Alcon Research, Ltd. | Method of treating dry eye disorders |
KR20150017002A (ko) | 2006-03-17 | 2015-02-13 | 존슨 앤드 존슨 비젼 케어, 인코포레이티드 | 산화에 불안정한 성분을 포함하는 안정화된 눈용 조성물 |
DK2010096T3 (en) | 2006-03-31 | 2017-10-02 | Mati Therapeutics Inc | NASOLACRIMAL DRAINAGE SYSTEM IMPLANTS FOR PHARMACEUTICAL THERAPY |
RU2010112417A (ru) | 2007-09-07 | 2011-10-10 | Клт Плаг Диливери, Инк. (Us) | Обнаружение лакримальных имплантатов |
US8207226B1 (en) | 2008-06-03 | 2012-06-26 | Alcon Research, Ltd. | Use of FAAH antagonists for treating dry eye and ocular pain |
BR112012010586A2 (pt) | 2009-11-06 | 2016-03-22 | Alcon Res Ltd | suplementos nutricionais para alívio de segura no olho. |
AU2013201465B2 (en) | 2012-10-24 | 2016-03-03 | Rayner Surgical (Ireland) Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
TWI705812B (zh) | 2014-12-01 | 2020-10-01 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
US20190177407A1 (en) | 2016-06-20 | 2019-06-13 | Novartis Ag | Methods of treating dry eye disease using tnf alpha antagonists |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6310784A (ja) * | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
JPH02138215A (ja) * | 1988-08-05 | 1990-05-28 | Dai Ichi Seiyaku Co Ltd | 抗アレルギー・抗炎症剤 |
IE920499A1 (en) * | 1991-02-21 | 1992-08-26 | Merck Frosst Canada Inc | Quinoline-containing ketoacids as leukotriene antagonists |
ZA924953B (en) * | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
JP3453152B2 (ja) * | 1992-04-06 | 2003-10-06 | 格 冨山 | 抗炎症点眼剤 |
FR2701948B1 (fr) * | 1993-02-22 | 1996-07-26 | Exsymol Sa | Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires. |
WO1994022448A1 (en) * | 1993-03-26 | 1994-10-13 | Beth Israel Hospital Association | Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses |
FR2711990B1 (fr) * | 1993-11-05 | 1995-12-08 | Exsymol Sa | Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires. |
JP2852607B2 (ja) * | 1994-06-10 | 1999-02-03 | 雪印乳業株式会社 | ドライアイ治療剤 |
US5641805A (en) * | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
JPH1067684A (ja) * | 1996-06-17 | 1998-03-10 | Mitsubishi Chem Corp | 涙液分泌促進剤 |
JP2002514194A (ja) * | 1996-11-19 | 2002-05-14 | ザ スキーペンズ アイ リサーチ インスティテュート インコーポレイテッド | 角膜移植拒否又は眼疾におけるil―1raの局所使用 |
-
1999
- 1999-06-15 KR KR1020007004037A patent/KR100598723B1/ko not_active IP Right Cessation
- 1999-06-15 JP JP2000559840A patent/JP2002520355A/ja not_active Withdrawn
- 1999-06-15 AU AU45634/99A patent/AU742237B2/en not_active Ceased
- 1999-06-15 CN CN99801501A patent/CN1114401C/zh not_active Expired - Fee Related
- 1999-06-15 CA CA002306393A patent/CA2306393C/en not_active Expired - Fee Related
- 1999-06-15 DK DK99928600T patent/DK1037627T3/da active
- 1999-06-15 BR BR9906772-2A patent/BR9906772A/pt not_active Application Discontinuation
- 1999-06-15 PT PT81300632T patent/PT1037627E/pt unknown
- 1999-06-15 AT AT99928600T patent/ATE203668T1/de active
- 1999-06-15 EP EP99928600A patent/EP1037627B1/en not_active Expired - Lifetime
- 1999-06-15 DE DE69900207T patent/DE69900207T2/de not_active Expired - Lifetime
- 1999-06-15 WO PCT/US1999/013275 patent/WO2000003705A1/en active IP Right Grant
- 1999-06-15 ES ES99928600T patent/ES2159209T3/es not_active Expired - Lifetime
- 1999-06-25 TW TW088110742A patent/TW561046B/zh not_active IP Right Cessation
- 1999-07-13 AR ARP990103415A patent/AR019916A1/es unknown
-
2000
- 2000-03-29 ZA ZA200001593A patent/ZA200001593B/xx unknown
-
2001
- 2001-02-14 HK HK01101081A patent/HK1030362A1/xx not_active IP Right Cessation
- 2001-08-20 GR GR20010401273T patent/GR3036422T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
BR9906772A (pt) | 2000-09-26 |
CA2306393C (en) | 2008-12-23 |
WO2000003705A1 (en) | 2000-01-27 |
KR100598723B1 (ko) | 2006-07-11 |
AR019916A1 (es) | 2002-03-27 |
CA2306393A1 (en) | 2000-01-27 |
CN1275078A (zh) | 2000-11-29 |
KR20010024508A (ko) | 2001-03-26 |
AU742237B2 (en) | 2001-12-20 |
AU4563499A (en) | 2000-02-07 |
DE69900207D1 (de) | 2001-09-06 |
HK1030362A1 (en) | 2001-05-04 |
CN1114401C (zh) | 2003-07-16 |
PT1037627E (pt) | 2001-11-30 |
EP1037627B1 (en) | 2001-08-01 |
DE69900207T2 (de) | 2001-11-22 |
JP2002520355A (ja) | 2002-07-09 |
EP1037627A1 (en) | 2000-09-27 |
GR3036422T3 (en) | 2001-11-30 |
ES2159209T3 (es) | 2001-09-16 |
ATE203668T1 (de) | 2001-08-15 |
TW561046B (en) | 2003-11-11 |
DK1037627T3 (da) | 2001-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200001593B (en) | Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz [B,E] oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization. | |
HK1085647A1 (en) | Benzo [d]azepine derivatives for the treatment of neurological disorders | |
EP1100508B8 (en) | Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone and brotizolam for treating or preventing sleep disorders | |
IL113912A (en) | Use of 2-methyl-10-(4-methyl-1- piperazinyl)-4h-thieno-[2,3-b] [1,5] benzodiazepine for the treatment of functional bowel disorders | |
MY116651A (en) | Topical ophthalmic formulations for treating allergic eye diseases | |
HUP0000576A3 (en) | Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts | |
IL153425A0 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
HK1023293A1 (en) | New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders | |
BG106509A (en) | Preparative form | |
EP1440689A3 (en) | Treatment of neurotic disorders | |
NO20013645L (no) | Anvendelse av pyridazino[4,5-b]indol-1-acetamid-derivater for fremstilling av medisiner for behandling av sykdommer relatert tildysfunksjon av de perifere benzodiazepinreseptorer | |
AU2001256855A1 (en) | Preparation for the prevention and treatment of ocular disorders | |
EP1126850A4 (en) | TREATMENT OF CONDITIONS OF THE RETINA | |
GB9926968D0 (en) | Treatment of neurological disorders | |
AU1546101A (en) | Pharmaceutical compositions comprising acetylcholinesterase antisense deoxynucleotides for the treatment of muscular and neuromuscular disorders | |
AU5912900A (en) | Quinuclidine derivatives for treatment of neurological disorders | |
WO2002043715A3 (de) | Verwendung von 1-phenyl-3-dimethylamino-propanverbindungen zur therapie der harninkontinenz | |
AU6386700A (en) | Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies | |
IL150290A (en) | Use of mirtazapine for preparation of a medicament for the treatment of sleep disorders | |
HK1047695A1 (en) | Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina | |
CA2260863A1 (en) | Treatment of psychotic disorders | |
MXPA01003761A (es) | Agente para tratar oftalmopatia. | |
WO2002043714A3 (de) | Verwendung von substituierten 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz | |
WO2002043712A3 (de) | Verwendung von 6-dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur therapie der harninkontinenz | |
IL149669A0 (en) | NEW THERAPEUTIC COMBINATIONS OF (S) -2-(BENZYLAMINO-METHYL)-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e] INDOL-8-ONE AND NEUROLEPTICS FOR THE TREATMENT OR PREVENTION OF PSYCHOTIC DISORDERS |